MarketFriction

Torrent Cables Ltd

BSE 523856 · Pharmaceuticals
Market cap₹Cr.
Not trading

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Mar 2013Jun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015
Sales75.4548.4638.0661.9567.1162.2241.1676.7891.4292.34
Expenses68.3146.0938.4359.8263.5460.6441.8474.5086.5585.38
Operating Profit7.142.37-0.372.133.571.58-0.682.284.876.96
OPM %9.46%4.89%-0.97%3.44%5.32%2.54%-1.65%2.97%5.33%7.54%
Other Income0.351.131.691.271.370.861.170.810.440.38
Interest0.410.000.110.020.210.040.000.190.340.13
Depreciation1.961.951.592.001.891.981.981.992.001.88
Profit before tax5.121.55-0.381.382.840.42-1.490.912.975.33
Tax %26.56%18.06%-18.42%-0.72%30.99%23.81%-52.35%50.55%-11.78%9.19%
Net Profit3.771.27-0.311.391.960.32-0.710.453.314.84
EPS in Rs4.381.48-0.361.622.280.37-0.830.523.855.63
Jun 2006 15mJun 2007Jun 2008Mar 2009 9mMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015TTM
Sales70215133167251320376216272302
Expenses190177122163236286343208264288
Operating Profit-12-0381051535338813
OPM %-161%18%8%2.8%6%11%9%3.7%3.0%4.5%
Other Income-442548311533
Interest00011222011
Depreciation110322888788
Profit before tax-6714011982624538
Tax %0%0%-19%11%-12%18%26%26%20%-20%
Net Profit-67147101071918438
EPS in Rs11.7112.218.0022.4320.845.023.929.17
Dividend Payout %0%0%0%26%25%31%16%17%30%26%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%10%-5%32%
Compounded Profit Growth%-20%-44%135%
Stock Price CAGR%%%%
Return on Equity%7%5%2%
Jun 2006Jun 2007Jun 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015
Equity Capital454519999999
Reserves-100-99108115122127143157160162
Borrowings734401010117050
Other Liabilities20213125303438232121
Total Liabilities3810140158171180197189195192
Fixed Assets001715706760585446
CWIP00130105000
Investments00260000000
Other Assets381096113101113133131141145
Total Assets3810140158171180197189195192
Jun 2006Jun 2007Jun 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015
Cash from Operating Activity-03348105102014-15
Cash from Investing Activity530-31-1-25-1-3-111
Cash from Financing Activity-24-29-06-2-5-8-131-7
Net Cash Flow29-26413-17-1-1716-21
Free Cash Flow53328-21-17151810-16
CFO/OP1%-600%119%81%62%42%27%79%191%-175%
Jun 2006Jun 2007Jun 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015
Debtor Days1771201088010385121115
Inventory Days05998786246348275
Days Payable2035463438122521
Cash Conversion Cycle1116183140108110106178168
Working Capital Days-747103175139919799159165
ROCE %33%81%19%7%7%19%16%3%2%

Fundamentals

Market Cap₹ Cr.
Current Price₹
Book Value₹
ROCE1.97 %
ROE1.99 %
Dividend Yield%
Face Value₹ 10.0
Compounded Sales Growth (TTM)32%
Compounded Profit Growth (TTM)135%
Standalone figures.
Profitability
Operating margin (excl. other income)2.97%
Operating margin (incl. other income)4.18%
EBITDA margin5.35%
Pre-tax margin2.56%
Net profit margin2.62%
Net margin, latest quarter5.24%
ROE1.99%
ROCE1.97%
ROA1.74%
ROE, 3-year average5.30%
ROCE, 3-year average7.25%
ROA, 3-year average4.43%
ROE, 5-year average6.90%
ROCE, 5-year average9.52%
ROA, 5-year average5.49%
ROIC (approx.)5.94%
Tax rate-19.93%
Other income / net worth1.92%
Growth
Sales growth (latest year)25.98%
Profit growth (latest year)-21.99%
Sales CAGR, 3 years-5.35%
Sales CAGR, 5 years10.19%
Profit CAGR, 3 years-44.10%
Profit CAGR, 5 years-20.33%
Sales growth QoQ1.01%
Profit growth QoQ46.22%
Sales growth YoY (latest quarter)48.41%
Profit growth YoY (latest quarter)1412.50%
Per share
EPS (TTM)Rs 9.18
EPS (latest year)Rs 3.92
EPS (latest quarter)Rs 5.63
EPS, 3-year averageRs 9.93
EPS, 5-year averageRs 12.04
Book value per shareRs 198.39
Sales per shareRs 350.88
Cash flow per shareRs -17.11
Free cash flow per shareRs -18.61
Dividend per share (latest year)Rs 1.00
Dividend per share, 3-year averageRs 2.00
Dividend per share, 5-year averageRs 2.40
Dividends
Dividend payout25.52%
Dividend payout, 3-year average24.06%
Dividend payout, 5-year average23.81%
Efficiency
Asset turnover1.42x
Fixed asset turnover5.85x
Inventory turnover5.42x
Inventory days67 days
Debtor days115 days
Debtors turnover3.18x
Creditor days21 days
Cash conversion cycle168 days
Working capital days165 days
Leverage
Total debtRs 0 Cr
Cash and bankRs 3 Cr
Net debtRs -3 Cr
Debt to equity0.00x
Net debt / EBITDA-0.19x
Interest coverage14.31x
Owners' fund to total sources89.01%
Debt to assets0.11%
Cash flow
Cash from Operating Activity (latest year)Rs -15 Cr
Cash from Investing Activity (latest year)Rs 1 Cr
Cash from Financing Activity (latest year)Rs -7 Cr
Net Cash Flow (latest year)Rs -21 Cr
Free cash flow (latest year)Rs -16 Cr
FCFE (approx.: FCF + change in debt)Rs -21 Cr
Cash from ops / profit, 5 years0.67x
Statement figures
Net sales (TTM)Rs 302 Cr
Net sales (latest year)Rs 272 Cr
Sales (latest quarter)Rs 92 Cr
Operating profit excl. other income (latest year)Rs 8 Cr
Operating profit (latest quarter)Rs 7 Cr
Other income (TTM)Rs 3 Cr
EBITDA (TTM)Rs 16 Cr
PBDT (TTM)Rs 16 Cr
Profit before tax (TTM)Rs 8 Cr
Tax (latest year)Rs -1 Cr
Net profit (TTM)Rs 8 Cr
Net profit (latest year)Rs 3 Cr
Net profit (latest quarter)Rs 5 Cr
Depreciation (TTM)Rs 8 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 238 Cr
Total expenditure (latest year)Rs 264 Cr
Total income (latest year)Rs 275 Cr
Share capitalRs 9 Cr
ReservesRs 162 Cr
Shareholders' fundsRs 171 Cr
Total assetsRs 192 Cr
Net blockRs 46 Cr
Capital work in progressRs 0 Cr
ReceivablesRs 85 Cr
InventoryRs 44 Cr
Other liabilitiesRs 21 Cr
Shares outstanding (crore)0.86
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.

Red flags

F-score 4 of 8
lookProfit leans on other income Other income was 117% of pre-tax profit in 2015
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2015
Sales ₹92 Cr +48.4% vs Jun 2014. Net profit ₹5 Cr +1412.5%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Sun Pharmaceutical Industries Ltd447,47635.420.5 %
Divis Laboratories Ltd250,36384.022.0 %
Torrent Pharmaceuticals Ltd186,15283.415.2 %
Zydus Lifesciences Ltd119,75024.621.1 %
Cipla Ltd111,43031.115.5 %
Laurus Labs Ltd106,92897.817.8 %
Mankind Pharma Ltd105,12049.313.5 %
Dr Reddys Laboratories Ltd104,49432.413.0 %
Aurobindo Pharma Ltd97,68225.812.9 %
Lupin Ltd93,84015.829.9 %
Glenmark Pharmaceuticals Ltd68,90522.139.8 %
Alkem Laboratories Ltd62,77227.621.2 %
Biocon Ltd61,43984.53.61 %
Abbott India Ltd57,94935.944.8 %
Gland Pharma Ltd49,33343.115.1 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Torrent Cables Ltd?

Torrent Cables Ltd (523856) has a market capitalisation of Rs Cr. at the close.

What were Torrent Cables Ltd's latest quarterly results?

In the Jun 2015 quarter, Torrent Cables Ltd sales was Rs 92 Cr (+48.4% vs Jun 2014) and net profit was Rs 5 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03